PACS Group (PACS) director reports 4,399 restricted stock unit award

Rhea-AI Filing Summary

PACS Group, Inc. reported an insider equity award for one of its directors. On 12/19/2025, the director acquired 4,399 restricted stock units (RSUs) of PACS Group common stock at a price of $0 per unit as reported on a Form 4. Each RSU entitles the holder to receive one share of common stock upon vesting.

The filing states that 100% of the RSUs will vest on the earlier of December 19, 2026 or the date of the next annual meeting following the grant date, provided the director continues to serve the company. Following this award, the director beneficially owns 27,138 shares of PACS Group common stock in total.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dilsaver Evelyn S

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UT 84101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/19/2025		A		4,399(1)	A	$0	27,138	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) December 19, 2026 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	12/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PACS Group (PACS) report in this Form 4?

The filing reports that a director of PACS Group, Inc. acquired 4,399 restricted stock units (RSUs) of PACS Group common stock on 12/19/2025 at a price of $0 per unit.

How many PACS Group RSUs were granted and what do they represent?

The director received 4,399 RSUs. Each RSU represents the right to receive one share of PACS Group common stock upon vesting.

When do the newly granted PACS Group (PACS) RSUs vest?

The Form 4 states that 100% of the RSUs will vest on the earlier of December 19, 2026 or the date of the next annual meeting following the grant date, subject to the director’s continued service.

What is the director’s total PACS Group stock ownership after this transaction?

After the reported RSU grant, the director beneficially owns 27,138 shares of PACS Group, Inc. common stock.

Was this PACS Group (PACS) equity award a purchase for cash?

No. The Form 4 lists the transaction as an acquisition of RSUs at a price of $0 per unit, indicating an equity compensation grant rather than a cash purchase.

What type of relationship does the reporting person have with PACS Group (PACS)?

The filing identifies the reporting person’s relationship to PACS Group, Inc. as a Director.